Digital Symptom Monitoring for Breast Cancer

KL
Overseen ByKimberley Lee
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Abramson Cancer Center at Penn Medicine
Must be taking: Oral endocrine therapy
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of the study is to learn more about ways to help patients understand and manage side-effects from hormone therapy. The investigators will use the information from this study to design future studies to better understand how our well our tools work to help patients monitor and manage symptoms from hormone therapy and to stay on their hormone therapy for the recommended period of time.

Who Is on the Research Team?

KL

Kimberley Lee, MD

Principal Investigator

University of Pennsylvania

Are You a Good Fit for This Trial?

Inclusion Criteria

I finished chemotherapy at least 14 days ago.
* Capable of using the electronic pill bottle
I identify as a woman.
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a web-based intervention for symptom monitoring and health promotion for endocrine therapy

48 weeks
Regular virtual check-ins

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Digital Endocrine therapy Symptom Monitoring and Education Intervention

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: ARM A InterventionExperimental Treatment1 Intervention
Group II: ARM B Usual careActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Abramson Cancer Center at Penn Medicine

Lead Sponsor

Trials
425
Recruited
464,000+

Fox Chase Cancer Center

Collaborator

Trials
236
Recruited
39,300+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+